623 related articles for article (PubMed ID: 12099190)
21. Patients' resistance to risk information in genetic counseling for BRCA1/2.
Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
[TBL] [Abstract][Full Text] [Related]
22. Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations.
d'Agincourt-Canning L; Baird P
Crit Rev Oncol Hematol; 2006 May; 58(2):114-23. PubMed ID: 16600617
[TBL] [Abstract][Full Text] [Related]
23. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
Hutson SP
Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
[TBL] [Abstract][Full Text] [Related]
24. Development of the breast cancer education and risk assessment program.
Snyder LA; Soballe DB; Lahl LL; Nehrebecky ME; Soballe PW; Klein PM
Oncol Nurs Forum; 2003; 30(5):803-8. PubMed ID: 12949593
[TBL] [Abstract][Full Text] [Related]
25. [Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].
Radulović S; Branković-Magić M; Janković R; Ristanović M
Srp Arh Celok Lek; 2003; 131(7-8):345-50. PubMed ID: 14692152
[TBL] [Abstract][Full Text] [Related]
26. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
[TBL] [Abstract][Full Text] [Related]
27. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):603-6. PubMed ID: 15254451
[TBL] [Abstract][Full Text] [Related]
28. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
Metcalfe A; Werrett J; Burgess L; Clifford C
Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
[TBL] [Abstract][Full Text] [Related]
29. [Psychological aspects of predictive genetic diagnosis in breast and ovarian carcinoma].
Tiefensee I; Klusmann D
Psychother Psychosom Med Psychol; 1998; 48(9-10):369-74. PubMed ID: 9785966
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
31. Genetics and the multidisciplinary breast center.
Peters JA; Rubinstein WS
Surg Oncol Clin N Am; 2000 Apr; 9(2):367-96. PubMed ID: 10757850
[TBL] [Abstract][Full Text] [Related]
32. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
[TBL] [Abstract][Full Text] [Related]
33. Genetic risk assessment for breast and ovarian cancer.
O'Rourke Tiffen J; Pfeifer K; Fishman DA
Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
[No Abstract] [Full Text] [Related]
34. Genetic testing for breast and ovarian cancer susceptibility: a family experience.
Van Riper M; McKinnon WC
J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674
[TBL] [Abstract][Full Text] [Related]
35. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.
Macdonald KG; Doan B; Kelner M; Taylor KM
CMAJ; 1996 Feb; 154(4):457-64. PubMed ID: 8630835
[TBL] [Abstract][Full Text] [Related]
36. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
Brunsvold AN; Wung SF; Merkle CJ
J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
[TBL] [Abstract][Full Text] [Related]
38. Cancer genetics in primary care.
Culler D; Grimes SJ; Acheson LS; Wiesner GL
Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
[TBL] [Abstract][Full Text] [Related]
39. Assessing hereditary breast cancer risk.
Cancer Pract; 1999; 7(6):279-84. PubMed ID: 10732524
[No Abstract] [Full Text] [Related]
40. Awareness of genetic testing for breast cancer risk among women with a family history of breast cancer: effect of women's information sources on their awareness.
Meischke H; Bowen D; Kuniyuki A
Cancer Detect Prev; 2001; 25(4):319-27. PubMed ID: 11531008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]